Gujarat, INDIA (June 2026) – Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), a pharmaceutical API manufacturing and drug development company, successfully completed an inspection by the Ministry of Food and Drug Safety (MFDS), Republic of Korea, at its Naroda manufacturing facility.

DCAL is pleased to announce the successful completion of an inspection by the Ministry of Food and Drug Safety (MFDS), Republic of Korea, at its Naroda manufacturing site.

The successful inspection reflects the continued strength of the site's quality management systems, regulatory compliance framework, and operations. It reinforces the company's commitment to maintaining the highest standards of quality, patient safety, and Good Manufacturing Practices (GMP).

"The successful completion of the MFDS inspection underscores our unwavering commitment to quality, compliance, and operational excellence. This achievement also reflects the dedication and expertise of our teams, whose relentless focus enables us to consistently meet the best standards expected by global regulatory authorities and customers. This milestone also reinforces our global footprint and enhances our ability to accelerate growth across the APAC region, underpinned by trust and long-term partnerships.”

— [Paolo Armanino], Chief Operating Officer, DCAL

As a trusted global partner to the pharmaceutical industry, DCAL remains focused on continuously enhancing its capabilities while delivering reliable and compliant solution worldwide aimed at patient safety and customer success.